Literature DB >> 9113005

End of the line for "third-generation-pill" controversy?

J P Vandenbroucke1, F R Rosendaal.   

Abstract

Keywords:  Biology; Blood Coagulation Effects; Contraception; Contraceptive Methods--side effects; Critique; Developed Countries; Diseases; Embolism; Europe; Evaluation; Family Planning; Hematological Effects; Hemic System; Netherlands; Oral Contraceptives, Combined--side effects; Oral Contraceptives--side effects; Physiology; Risk Assessment; Thromboembolism; Vascular Diseases; Western Europe

Mesh：

Substances：

Year:  1997        PMID： 9113005     DOI： 10.1016/S0140-6736(05)63015-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Cardiovascular events associated with different combined oral contraceptives: a review of current data.

Authors:  P Hannaford
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  Pharmacovigilance in the pharmaceutical industry.

Authors:  J C Talbot; B S Nilsson
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

Review 3.  Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review.

Authors:  J Castellsague; S Pérez Gutthann; L A García Rodríguez
Journal:  Drug Saf       Date:  1998-02       Impact factor: 5.606

Review 4.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.